UBS analyst Karl Keirstead raised the firm’s price target on Oracle (ORCL) to $380 from $360 and keeps a Buy rating on the shares. Oracle raised its FY30 revenue guidance and backlog metrics at its investor day, the analyst tells investors in a research note. UBS believes the stock can move higher as it executes on this guidance acceleration.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ORCL:
- Oracle’s Strong Growth Potential and Strategic Positioning Highlighted in Buy Rating
- Oracle’s Strategic Growth and AI Positioning Reinforce Buy Rating
- Oracle’s Promising Growth Trajectory: Buy Rating Backed by Ambitious Revenue Targets and Strategic AI Initiatives
- AMD price target raised to $300 from $250 at BofA
- Oracle price target raised to $400 from $367 at Barclays